Raloxifene (Evista) is used to treat osteoporosis (bone loss) and lower the risk of breast cancer in women who've gone through menopause. This medication belongs to the drug class known as selective estrogen receptor modulators (SERMs). Raloxifene (Evista) is a tablet that's taken once a day. Side effects can include hot flashes, headaches, and joint pain.
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM). It either acts like estrogen or blocks the activity of estrogen, depending on where the medication works in the body.
In your bones, raloxifene (Evista) acts like estrogen. This helps prevent bone breakdown and improve bone mineral density (BMD), which is a measure of how dense your bones are. A higher BMD means your bones are stronger, which helps lower your risk of bone fractures.
In your breast, raloxifene (Evista) blocks estrogen from entering cells. This prevents estrogen from turning on signals that make breast cells cancerous.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Stop taking this medicine and get emergency help immediately if any of the following effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
More common
Bloody or cloudy urine
difficult, burning, or painful urination
frequent urge to urinate
infection, including body aches or pain, congestion in throat, cough, dryness or soreness of throat, runny nose, and loss of voice
leg cramping
skin rash
swelling of hands, ankles, or feet
vaginal itching
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Hot flashes, including sudden sweating and feelings of warmth (especially common during the first 6 months of treatment)
increased white vaginal discharge
joint or muscle pain
mental depression
problems of stomach or intestines, including passing of gas, upset stomach, or vomiting
swollen joints
trouble in sleeping
weight gain (unexplained)
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
It can take about 5 to 6 days for most of raloxifene (Evista) to leave your body. This time frame is estimated based on the half-life of the medication.
No, raloxifene (Evista) isn't a bisphosphonate. Bisphosphonates, like alendronate (Fosamax), and raloxifene (Evista) both help with osteoporosis by preventing bone from breaking down. But the two types of medications work a little differently. Raloxifene (Evista) is a selective estrogen receptor modulator (SERM). In the bones, the medication acts like estrogen to prevent bone breakdown.
There isn't a set amount of time that you should take raloxifene (Evista) for osteoporosis. In clinical studies, people generally took the medication for at least a few years. You'll probably continue to take raloxifene (Evista) as long as it's working to improve your bone strength and until your provider determines that your bones are healthy enough to stop. Your provider will routinely order DEXA scans to check your bone density. Speak with your provider about how long you should take raloxifene (Evista).
Raloxifene (Evista) can help lower your risk for invasive breast cancer if you've already been through menopause and either have osteoporosis or are at high risk for breast cancer. But the medication doesn't completely get rid of the possibility that you might develop breast cancer. Raloxifene (Evista) is also not approved to treat breast cancer or lower the risk that any breast cancer comes back. Continue to get routine breast scans (mammograms) and regularly check your breasts for any lumps or unusual changes to screen for breast cancer.
In a study looking at using raloxifene (Evista) to prevent osteoporosis in postmenopausal women, 9% of women who took the medication reported weight gain. It's important to note that hormonal changes in the body during menopause and other factors can also contribute to weight gain. Because raloxifene (Evista) is used in women who've gone through menopause, any weight gain that you might notice while you're taking raloxifene (Evista) might also be related to this stage in life. Speak with your healthcare provider if you're concerned about any changes in weight while you're taking this medication.
Hair loss wasn't a reported side effect of raloxifene (Evista) in clinical studies. Talk with your healthcare provider if you notice any hair loss or hair thinning while you're taking this medication. Your provider can examine you for possible causes of hair loss.
Jaw problems called osteonecrosis of the jaw (ONJ) weren't reported by people who took raloxifene (Evista) in clinical studies. Tell your provider or dentist if you have jaw pain or swelling or drainage in the mouth. Your provider will need to examine your mouth or jaw to check what's going on.
Yes, raloxifene (Evista) works to prevent bone from breaking down and to increase your bone density. This means that the medication can make your bones stronger and lower your risk of bone fractures. In particular, raloxifene (Evista) works well to lower the risk of back fractures in postmenopausal women. Your provider will order DEXA scans to periodically check your bone density and see how well raloxifene (Evista) is working for you.
Both raloxifene (Evista) and tamoxifen are selective estrogen receptor modulators (SERMs). They're both approved to lower the risk of breast cancer in women who are considered at high risk. Studies suggest that the two medications work just as well as each other to prevent invasive breast cancer. But they also have a few differences. For example, raloxifene is only approved for women who’ve gone through menopause, whereas tamoxifen can be taken by both premenopausal and postmenopausal women. In addition, raloxifene is also approved to treat and prevent osteoporosis, whereas tamoxifen isn't. Speak with your provider to learn more about the similarities and differences between raloxifene and tamoxifen.
Raloxifene (Evista) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Raloxifene (Evista) can raise your risk of blood clots. The risk for clots appears to be greatest during the first 4 months of treatment. Blood clots can lead to life-threatening complications, such as stroke.
Let your healthcare provider know about your medical history, especially if you've had a blood clot or stroke before. Your provider can discuss the risks and benefits of taking raloxifene (Evista). You won't be able to take this medication if you've had any blood clots in the past.
Get emergency help right away if you have pain in your arms or legs, bad headaches, trouble breathing, sudden changes in your speech or vision, or sudden weakness on one side of your body. These can be signs of a blood clot or stroke.
It's possible for your triglyceride (fat) levels to go up while you're taking raloxifene (Evista) if your triglyceride levels are already high as a side effect of other estrogen medications. Your healthcare provider will order regular blood tests for you to get done while you're taking raloxifene (Evista) if you're at risk for very high triglyceride levels.
Raloxifene (Evista) helps prevent breast cancer, but it doesn't completely get rid of the risk. Continue to get breast scans (mammograms) and regularly check your breasts for any lumps or changes. Talk to your healthcare provider if you notice any unusual changes in shape, size, or color of your breast.
Taking raloxifene (Evista) with warfarin (Coumadin) might raise the risk for side effects from the blood thinner, most notably bleeding. Let the healthcare provider who's managing your warfarin know that you're taking raloxifene (Evista). You might need to do blood tests when you start or stop taking raloxifene (Evista) to make sure the warfarin levels in your body are safe. Tell your healthcare provider if you notice more bleeding than usual, such as nosebleeds lasting more than 10 minutes or severe bruising.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 60mg | 90 tablets | $34.15 | $0.38 |
The typical dose is 60 mg by mouth once daily.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Raloxifene (Evista) will not be safe for you to take.